中泰化學(002092.SZ):擬以16.65億元現金增資全資子公司中泰礦冶
格隆匯 9 月 29日丨中泰化學(002092.SZ)公佈,全資子公司新疆中泰礦冶有限公司(以下簡稱“中泰礦冶”)是中泰化學重要的電石原料生產基地。為了優化中泰礦冶的資產負債結構,改善財務狀況,增強中泰礦冶的整體營運能力,中泰化學擬以16.65億元現金增資中泰礦冶,本次增資擴股完成後,中泰礦冶仍為中泰化學全資子公司。
本次對外投資不構成關聯交易,亦不構成《上市公司重大資產重組管理辦法》規定的重大資產重組,不需提交公司股東大會審議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.